Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Jul;86(1):265–272. doi: 10.1172/JCI114694

Human growth hormone prevents the protein catabolic side effects of prednisone in humans.

F F Horber 1, M W Haymond 1
PMCID: PMC296716  PMID: 2195062

Abstract

Prednisone treatment causes protein wasting and adds additional risks to a patient, whereas human growth hormone (hGH) treatment causes positive nitrogen balance. To determine whether concomitant administration of hGH prevents the protein catabolic effects of prednisone, four groups of eight healthy volunteers each were studied using isotope dilution and nitrogen balance techniques after 7 d of placebo, hGH alone (0.1 mg.kg-1.d-1), prednisone alone (0.8 mg.kg-1.d-1), or prednisone plus hGH (n = 8 in each group). Whether protein balance was calculated from the leucine kinetic data or nitrogen balance values, prednisone alone induced protein wasting (P less than 0.001), whereas hGH alone resulted in positive (P less than 0.001) protein balance, when compared to the placebo-treated subjects. When hGH was added to prednisone therapy, the glucocorticoid-induced protein catabolism was prevented. Using leucine kinetic data, negative protein balance during prednisone was due to increased (P less than 0.05) proteolysis, whereas hGH had no effect on proteolysis and increased (P less than 0.01) whole body protein synthesis. During combined treatment, estimates of proteolysis and protein synthesis were similar to those observed in the placebo treated control group. In conclusion, human growth hormone may have a distinct role in preventing the protein losses associated with the administration of pharmacologic doses of glucocorticosteroids in humans.

Full text

PDF
265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abumrad N. N., Rabin D., Diamond M. P., Lacy W. W. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism. 1981 Sep;30(9):936–940. doi: 10.1016/0026-0495(81)90074-3. [DOI] [PubMed] [Google Scholar]
  2. Brenner B. M., Meyer T. W., Hostetter T. H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–659. doi: 10.1056/NEJM198209093071104. [DOI] [PubMed] [Google Scholar]
  3. Cheek D. B., Hill D. E. Muscle and liver cell growth: role of hormones and nutritional factors. Fed Proc. 1970 Jul-Aug;29(4):1503–1509. [PubMed] [Google Scholar]
  4. Clemmons D. R., Snyder D. K., Williams R., Underwood L. E. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab. 1987 May;64(5):878–883. doi: 10.1210/jcem-64-5-878. [DOI] [PubMed] [Google Scholar]
  5. Crist D. M., Peake G. T., Egan P. A., Waters D. L. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol (1985) 1988 Aug;65(2):579–584. doi: 10.1152/jappl.1988.65.2.579. [DOI] [PubMed] [Google Scholar]
  6. Felber J. P., Ferrannini E., Golay A., Meyer H. U., Theibaud D., Curchod B., Maeder E., Jequier E., DeFronzo R. A. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes. 1987 Nov;36(11):1341–1350. doi: 10.2337/diab.36.11.1341. [DOI] [PubMed] [Google Scholar]
  7. Fukagawa N. K., Minaker K. L., Rowe J. W., Goodman M. N., Matthews D. E., Bier D. M., Young V. R. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest. 1985 Dec;76(6):2306–2311. doi: 10.1172/JCI112240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fulks R. M., Li J. B., Goldberg A. L. Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem. 1975 Jan 10;250(1):290–298. [PubMed] [Google Scholar]
  9. Garrel D. R., Delmas P. D., Welsh C., Arnaud M. J., Hamilton S. E., Pugeat M. M. Effects of moderate physical training on prednisone-induced protein wasting: a study of whole-body and bone protein metabolism. Metabolism. 1988 Mar;37(3):257–262. doi: 10.1016/0026-0495(88)90105-9. [DOI] [PubMed] [Google Scholar]
  10. Golden M. H., Waterlow J. C. Total protein synthesis in elderly people: a comparison of results with [15N]glycine and [14C]leucine. Clin Sci Mol Med. 1977 Sep;53(3):277–288. doi: 10.1042/cs0530277. [DOI] [PubMed] [Google Scholar]
  11. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  12. Horber F. F., Hoopeler H., Scheidegger J. R., Grünig B. E., Howald H., Frey F. J. Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids. J Clin Invest. 1987 Apr;79(4):1181–1190. doi: 10.1172/JCI112935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Horber F. F., Horber-Feyder C. M., Krayer S., Schwenk W. F., Haymond M. W. Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis. Am J Physiol. 1989 Sep;257(3 Pt 1):E385–E399. doi: 10.1152/ajpendo.1989.257.3.E385. [DOI] [PubMed] [Google Scholar]
  14. Horber F. F., Kahl J., Lecavalier L., Krom B., Haymond M. W. Determination of leucine and alpha-ketoisocaproic acid concentrations and specific activity in plasma and leucine specific activities in proteins using high-performance liquid chromatography. J Chromatogr. 1989 Oct 27;495:81–94. doi: 10.1016/s0378-4347(00)82611-0. [DOI] [PubMed] [Google Scholar]
  15. Horber F. F., Krayer S., Rehder K., Haymond M. W. Anesthesia with halothane and nitrous oxide alters protein and amino acid metabolism in dogs. Anesthesiology. 1988 Sep;69(3):319–326. doi: 10.1097/00000542-198809000-00006. [DOI] [PubMed] [Google Scholar]
  16. Horber F. F., Scheidegger J. R., Grünig B. E., Frey F. J. Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab. 1985 Jul;61(1):83–88. doi: 10.1210/jcem-61-1-83. [DOI] [PubMed] [Google Scholar]
  17. Horber F. F., Scheidegger J. R., Grünig B. E., Frey F. J. Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest. 1985 Dec;15(6):302–307. doi: 10.1111/j.1365-2362.1985.tb00276.x. [DOI] [PubMed] [Google Scholar]
  18. Horber F. F., Scheidegger J., Frey F. J. Overestimation of renal function in glucocorticosteroid treated patients. Eur J Clin Pharmacol. 1985;28(5):537–541. doi: 10.1007/BF00544064. [DOI] [PubMed] [Google Scholar]
  19. Horber F. F., Zürcher R. M., Herren H., Crivelli M. A., Robotti G., Frey F. J. Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis. Am J Clin Nutr. 1986 May;43(5):758–769. doi: 10.1093/ajcn/43.5.758. [DOI] [PubMed] [Google Scholar]
  20. Jackson R. A., Peters N., Advani U., Perry G., Rogers J., Brough W. H., Pilkington T. R. Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes. 1973 Jun;22(6):442–458. doi: 10.2337/diab.22.6.442. [DOI] [PubMed] [Google Scholar]
  21. Jacob R., Barrett E., Plewe G., Fagin K. D., Sherwin R. S. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest. 1989 May;83(5):1717–1723. doi: 10.1172/JCI114072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jensen M. D., Braun J. S., Vetter R. J., Marsh H. M. Measurement of body potassium with a whole-body counter: relationship between lean body mass and resting energy expenditure. Mayo Clin Proc. 1988 Sep;63(9):864–868. doi: 10.1016/s0025-6196(12)62688-3. [DOI] [PubMed] [Google Scholar]
  23. LILJEDAHL S. O., GEMZELL C. A., PLANTIN L. O., BIRKE G. Effect of human growth hormone in patients with severe burns. Acta Chir Scand. 1961 Aug;122:1–14. [PubMed] [Google Scholar]
  24. Manson J. M., Wilmore D. W. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery. 1986 Aug;100(2):188–197. [PubMed] [Google Scholar]
  25. Nakaparksin S., Gil-Av E., Oró J. Study of the racemization of soe neutral alpha-amino acids in acid solution using gas chromatographic techniques. Anal Biochem. 1970 Feb;33(2):374–382. doi: 10.1016/0003-2697(70)90308-8. [DOI] [PubMed] [Google Scholar]
  26. Nissen S., Haymond M. W. Changes in leucine kinetics during meal absorption: effects of dietary leucine availability. Am J Physiol. 1986 Jun;250(6 Pt 1):E695–E701. doi: 10.1152/ajpendo.1986.250.6.E695. [DOI] [PubMed] [Google Scholar]
  27. Rizza R. A., Mandarino L. J., Gerich J. E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab. 1982 Jan;54(1):131–138. doi: 10.1210/jcem-54-1-131. [DOI] [PubMed] [Google Scholar]
  28. Rosenfeld R. G., Wilson D. M., Lee P. D., Hintz R. L. Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr. 1986 Sep;109(3):428–433. doi: 10.1016/s0022-3476(86)80112-3. [DOI] [PubMed] [Google Scholar]
  29. Schoeller D. A., Klein P. D. A microprocessor controlled mass spectrometer for the fully automated purification and isotopic analysis of breath carbon dioxide. Biomed Mass Spectrom. 1979 Aug;6(8):350–355. doi: 10.1002/bms.1200060809. [DOI] [PubMed] [Google Scholar]
  30. Schwenk W. F., Beaufrere B., Haymond M. W. Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol. 1985 Dec;249(6 Pt 1):E646–E650. doi: 10.1152/ajpendo.1985.249.6.E646. [DOI] [PubMed] [Google Scholar]
  31. Schwenk W. F., Berg P. J., Beaufrere B., Miles J. M., Haymond M. W. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem. 1984 Aug 15;141(1):101–109. doi: 10.1016/0003-2697(84)90431-7. [DOI] [PubMed] [Google Scholar]
  32. Shamoon H., Soman V., Sherwin R. S. The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans. J Clin Endocrinol Metab. 1980 Mar;50(3):495–501. doi: 10.1210/jcem-50-3-495. [DOI] [PubMed] [Google Scholar]
  33. Simmons P. S., Miles J. M., Gerich J. E., Haymond M. W. Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest. 1984 Feb;73(2):412–420. doi: 10.1172/JCI111227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Snyder D. K., Clemmons D. R., Underwood L. E. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab. 1988 Jul;67(1):54–61. doi: 10.1210/jcem-67-1-54. [DOI] [PubMed] [Google Scholar]
  35. Stacey-Schmidt C., Berg P., Haymond M. W. Use of D-glucosaminic acid as an internal standard in single-column accelerated amino acid analysis of physiological fluids. Anal Biochem. 1982 Jun;123(1):74–77. doi: 10.1016/0003-2697(82)90624-8. [DOI] [PubMed] [Google Scholar]
  36. Staten M. A., Bier D. M., Matthews D. E. Regulation of valine metabolism in man: a stable isotope study. Am J Clin Nutr. 1984 Dec;40(6):1224–1234. doi: 10.1093/ajcn/40.6.1224. [DOI] [PubMed] [Google Scholar]
  37. Tanner J. M., Hughes P. C., Whitehouse R. H. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency. Acta Endocrinol (Copenh) 1977 Apr;84(4):681–696. doi: 10.1530/acta.0.0840681. [DOI] [PubMed] [Google Scholar]
  38. Tessari P., Trevisan R., Inchiostro S., Biolo G., Nosadini R., De Kreutzenberg S. V., Duner E., Tiengo A., Crepaldi G. Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol. 1986 Sep;251(3 Pt 1):E334–E342. doi: 10.1152/ajpendo.1986.251.3.E334. [DOI] [PubMed] [Google Scholar]
  39. Uthne K., Reagan C. R., Gimpel L. P., Kostyo J. L. Effects of human somatomedin preparations on membrane transport and protein synthesis in the isolated rat diaphragm. J Clin Endocrinol Metab. 1974 Sep;39(3):548–554. doi: 10.1210/jcem-39-3-548. [DOI] [PubMed] [Google Scholar]
  40. Wilmore D. W., Moylan J. A., Jr, Bristow B. F., Mason A. D., Jr, Pruitt B. A., Jr Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet. 1974 Jun;138(6):875–884. [PubMed] [Google Scholar]
  41. Ziegler T. R., Young L. S., Manson J. M., Wilmore D. W. Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg. 1988 Jul;208(1):6–16. doi: 10.1097/00000658-198807000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES